Literature DB >> 1708128

Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene.

G Degols1, J P Leonetti, N Mechti, B Lebleu.   

Abstract

Several groups have reported the use of antisense oligonucleotides to inhibit c-myc gene expression and study its biological role. However high concentrations of free oligonucleotides were generally needed. To lower their concentration and stabilize the antisense effect against c-myc, oligonucleotides were covalently linked to poly(L-lysine) and administered in ternary complexes formed with heparin (100 micrograms/ml). A sequence specific growth inhibition was observed at concentrations lower than 1 microM, while oligonucleotide-poly(L-lysine) conjugates alone were inefficient. Similar results occurred with other polyanionic compounds. Inhibition of proliferation was correlated to a reduction of c-myc protein and to a transient decrease in c-myc mRNA level. However, implication of RNase H in this process could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708128      PMCID: PMC333736          DOI: 10.1093/nar/19.4.945

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  15 in total

1.  Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents. A common mechanism blocked by divalent cations.

Authors:  C L Bashford; G M Alder; G Menestrina; K J Micklem; J J Murphy; C A Pasternak
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

2.  A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro.

Authors:  A M Gewirtz; B Calabretta
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.

Authors:  J T Holt; R L Redner; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

5.  Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.

Authors:  M Lemaitre; B Bayard; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNA.

Authors:  G Degols; J P Leonetti; C Gagnor; M Lemaitre; B Lebleu
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

7.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

8.  Antiviral activity of conjugates between poly(L-lysine) and synthetic oligodeoxyribonucleotides.

Authors:  J P Leonetti; B Rayner; M Lemaitre; C Gagnor; P G Milhaud; J L Imbach; B Lebleu
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

9.  Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.

Authors:  J P Leonetti; G Degols; B Lebleu
Journal:  Bioconjug Chem       Date:  1990 Mar-Apr       Impact factor: 4.774

10.  Antisense oligonucleotide-directed cleavage of mRNA in Xenopus oocytes and eggs.

Authors:  J Shuttleworth; A Colman
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  8 in total

1.  Antisense delivery using protamine-oligonucleotide particles.

Authors:  M Junghans; J Kreuter; A Zimmer
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

2.  Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.

Authors:  D Morrissey; J O'Connell; D Lynch; G C O'Sullivan; F Shanahan; J K Collins
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

3.  Inhibition of ubiquitous mitochondrial creatine kinase expression in HeLa cells by an antisense oligodeoxynucleotide.

Authors:  N Enjolras; C Godinot
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

4.  Effects of antisense DNA on POMC mRNA and ACTH levels in cultured human corticotroph adenoma cells.

Authors:  M Woloschak; K Post; J L Roberts
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

5.  Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.

Authors:  M Simons; E R Edelman; R D Rosenberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

6.  Cloning and functional expression of an Aplysia 5-HT receptor negatively coupled to adenylate cyclase.

Authors:  A Angers; M V Storozhuk; T Duchaîne; V F Castellucci; L DesGroseillers
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

7.  The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.

Authors:  J O'Connell; G C O'Sullivan; J K Collins; F Shanahan
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

8.  The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines.

Authors:  T E Reichert; Y Kashii; J Stanson; A Zeevi; T L Whiteside
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.